New York Approves AssureRx's Lab | GenomeWeb

The story has been corrected to say that certification from New York is for AssureRx's laboratory not its GeneSightRx test.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The New York State Department of Health has certified AssureRx's laboratory, allowing residents in the state access to the company's pharmacogenomic test, GeneSightRx.

As a result of the approval, the Mason, Ohio-based company's laboratory is certified to analyze DNA samples for pharmacogenomic testing in all 50 states.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.